← Evidence map

ReviewHeliyon2023

Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome.

Xinyu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37810157